At Sarah Cannon, there has been a legacy of devotion to cancer research. Our team of collaborating SCRI sites have enrolled thousands of patients onto clinical trials.
By inhabiting the intersection where cutting-edge research meets compassionate care, we are redefining the standard for quality and excellence in oncology around the world.
SCRI presented 74 abstracts on latest cancer therapies at this year’s 2014 ASCO® Annual Meeting. Click here for a recap of ASCO® updates.
NewsSee All News >>
May 22 NASHVILLE, TN, May 22, 2014 – Sarah Cannon Research Institute...
Feb 26 Presence Reinforces Leadership Position in Transplantation
Jan 30 Integrated partnership expands cancer services in the Rocky Mountain...
A dedicated information service for our community of patients and partners.